David E. Kemp

Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome

David E. Kemp, Keming Gao, Philip K. Chan et al. · Bipolar Disorders · 2010 · 181 citations

Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar <scp>CHOICE</scp>)

Louisa G. Sylvia, Richard C. Shelton, David E. Kemp et al. · Bipolar Disorders · 2014 · 111 citations · Full text

A 6-Month, Double-Blind, Maintenance Trial of Lithium Monotherapy Versus the Combination of Lithium and Divalproex for Rapid-Cycling Bipolar Disorder and Co-Occurring Substance Abuse or Dependence

David E. Kemp, Keming Gao, Stephen J. Ganocy et al. · The Journal of Clinical Psychiatry · 2008 · 104 citations

Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity

David E. Kemp, Faramarz Ismail‐Beigi, Stephen J. Ganocy et al. · Journal of Affective Disorders · 2011 · 102 citations

Obesity, Metabolic Syndrome, Diabetes Management +15

PPAR-γ Agonism as a Modulator of Mood: Proof-of-Concept for Pioglitazone in Bipolar Depression

David E. Kemp, Martha Schinagle, Keming Gao et al. · CNS Drugs · 2014 · 100 citations · Full text

Psychiatry, Mood Symptom, Medicine +11